Receive news by e-mail

#
 

Enter your e-mail in the field below to receive directly the news that appears on this page.

 

topics : related - all Explore

Shopping

Top Product

You and Leukemia: A Day at a Time

Compare prices

  1. 2. 5,001 Reasons to Survive Leukemia: A Motivation Book
  2. 3. Leukemia: Acute myeloid leukemia, Acute lymphoblastic leukemia, Chronic myelogenous leukemia, Lymphoid leukemia, Myeloid leukemia
  3. 4. HealthScouter Leukemia: Leukemia Symptoms and facts about Leukemia: Symptoms of Leukemia or Leukemia Patient Advocate
  4. 5. Feline Leukemia Virus: Proceedings of the Third International Feline Leukemia Virus Meeting, St. Thomas, United States Virgin Islands, May 5- (Developments in Cancer Research)

Shopping Categories

  1. 1. Cell Phones
  2. 2. Smartphones
  3. 3. Digital Cameras
  4. 4. Laptop Computers
  5. 5. Processors
  6. 6. Motherboards
  7. 7. LCD Monitors
  8. 8. Graphics Cards
  9. 9. GPS
  10. 10. Digital Camcorders
  11. 11. Printers
  12. 12. Desktop Computers
  13. 13. Sedans
  14. 14. Coupes & Convertibles
  15. 15. 4x4

Wikio Shopping

  1. 1. Automotive
  2. 2. Beauty & Fragrances
  3. 3. Books
  4. 4. Car/Motorbike
  5. 5. CD
  6. 6. Clothing, Accessories & Shoes
  7. 7. Communication
  8. 8. Computers
  9. 9. DVD
  10. 10. Electronics
  11. 11. Flowers & Gifts
  12. 12. Gourmet & Foods
  13. 13. Health & Personal Care
  14. 14. Home & Garden
  15. 15. Hotels
  16. 16. Household Appliances
  17. 17. Jewelry & Watches
  18. 18. Musical Instruments
  19. 19. Sports & Outdoors
  20. 20. Toys & Baby
  21. 21. Video Games

Participate



Leukemia



Sort by : relevance - date - popularity
+Vote!

Advanced Leukemia Successfully Treated With First Use Of Antibody And Stem Cell Transplantation

For the first time, researchers at Fred Hutchinson Cancer Research Center have reported the use of a radiolabeled antibody to deliver targeted doses of radiation, followed by a stem cell transplant, to successfully treat a group of leukemia and pre-leukemia patients for whom there previously had been no other curative treatment options.

+Vote!

More about me...

Well now that the worst of it is hopefully over I feel better about writing about what is going on with me. I was diagnosed with a rare form of leukemia called "Hairy Cell". Yes, that is really what it is called. Only 2 in 2 million women get this and I was the lucky one. I've been in the hospital since Oct 19th. I've had my chemotherapy. It was 7 days long, 24 hours a day. I'm waiting now...

3Vote!

Kelly Brook Made Calendar Girl Debut

Talking about the role, Kelly said, “A few of the girls in the cast are more game than others to go nude.” The stage debut comes after a an intimate dinner at London restaurant J Sheekeys with boyfriend Danny Cipriani the previous evening. The cute couple recently moved in together, with Kelly telling, “It is only in the last few months that we have become an [official] couple and...

11Vote!

24-Year-Old Given Months To Live Without Insurance

As part of its Bearing Witness 2.0 project, the Huffington Post is rounding up a few of the best local stories of the day. Urangoo Baatarkhuyag, a Mongolian immigrant who moved to the United States eight years ago, has been told she will die because she does not have health insurance, reports Jed Boal for local NBC affiliate KSL . Baatarkhuyag, 24, was diagnosed with acute myeloid leukemia in September,...

5Vote!

Get a Jump on Your Holiday Shopping and Give Two Gifts This Season: One to Your Loved Ones and One to People Battling Blood Cancer

WHITE PLAINS, N.Y., Nov. 6 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) will again be participating in Gap Inc.'s Give & Get program, which in its first two campaigns this past spring and summer, garnered more than $1 million to support LLS's blood cancer research funding and patient education and support services.

4Vote!

Micromet takes back MedImmune's blinatumomab rights

Bethesda, MD-based Micromet has agreed to buy out MedImmune's North American rights to blinatumomab , a potential treatment for lymphoma and leukemia. As a result of the buyout, Micromet now controls global rights to develop and commercialize blinatumomab and any other BiTE antibodies for hematological cancers. The companies inked the blinatumomab agreement in 2003 and planned to create up to six...

3Vote!

Pivotal Data Published In The Journal Cancer Demonstrate That TREANDA Induced Durable Responses In Relapsed Indolent Non-Hodgkin's Lymphoma

Cephalon, Inc. (Nasdaq: CEPH) announced the journal Cancer has published a pivotal study demonstrating that TREANDA® (bendamustine HCl) for Injection induced durable responses in patients with indolent B-cell non-Hodgkin's lymphoma (NHL) whose disease had progressed during or within six months of treatment with rituximab.

3Vote!

Sunesis' Voreloxin Receives FDA Orphan Drug Designation For Acute Myeloid Leukemia

Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) announced that the U.S. Food and Drug Administration has granted voreloxin orphan drug designation for the treatment of acute myeloid leukemia (AML).

3Vote!

Stem Cell Therapy International, Inc. And Histostem Korea Announce Providing Hematopoietic Stem Cell To Queen Mary Hospital, Hong Kong

Stem Cell Therapy International Inc. (OTCBB: SCII) and its soon to be subsidiary, Histostem Ltd. of South Korea ("Histostem"), announced that they recently supplied hematopoietic stem cells to The Queen Mary Hospital of the University of Hong Kong, China, for treatment of Leukemia patients.

3Vote!

New Data On Bendamustine Offers Hope To Non-Hodgkin's Lymphoma Patients Resistant To Standard Therapy

New data published today in the journal, Cancer, reveals that three quarters (75%) of patients with indolent B-cell non-Hodgkin's lymphoma (iNHL), responded to treatment with Bendamustine following a single-arm, multicentre study. Significantly, all patients participating in the study had become resistant or were unresponsive to rituximab (the standard treatment for the disease) when used either as...

5Vote!

Sunesis leukemia drug gets FDA orphan drug designation

Sunesis Pharmaceuticals Inc. said Thursday the U.S. Food and Drug Administration granted orphan drug designation for voreloxin, its treatment of acute myeloid leukemia. (SNSS)

3Vote!

Oncogenic RAS Enables DNA Damage- and p53-Dependent Differentiation of Acute Myeloid Leukemia Cells in Response to Chemotherapy

Acute myeloid leukemia (AML) is a clonal disease originating from myeloid progenitor cells with a heterogeneous genetic background. High-dose cytarabine is used as the standard consolidation chemotherapy. Oncogenic RAS mutations are frequently observed in AML, and are associated with beneficial response to cytarabine. Why AML-patients with oncogenic RAS benefit most from high-dose cytarabine post-remission...

5Vote!

First Use Of Antibody And Stem Cell Transplantation To Successfully Treat Advanced Leukemia

For the first time, researchers have reported the use of a radiolabeled antibody to deliver targeted doses of radiation, followed by a stem cell transplant, to successfully treat a group of leukemia and pre-leukemia patients for whom there previously had been no other curative treatment options.

3Vote!

UT Southwestern Childhood-cancer Survivor Program Celebrates 20 Years

Alexandra Wilson was just 4 when she was diagnosed with acute lymphocytic leukemia, a cancer affecting blood and blood marrow. Eleven years after completing treatment at Children's Medical Center Dallas she experienced heart abnormalities as a result of her chemotherapy. The sophomore at UT Dallas now receives her follow-up treatment at UT Southwestern Medical Center.

5Vote!

Two genes cooperate to cause aggressive leukemia

Two genes, each one of which is known to cause cancer on its own, together can lead to aggressive leukaemia. This is the conclusion from new research carried out on gene-modified mice at the Sahlgrenska Academy at the University of Gothenburg, Sweden. The discovery has surprised scientists, and may lead to new treatments.

The 3 latest articles published by users on Leukemia :

4Vote!

Thromboembolism Therapy Area Pipeline Report

Thromboembolism Therapy Area Pipeline Report        - aarkstore

Acute Lymphoblastic Leukemia or Leukemia or Chronic Lymphocytic Leukemia or Chronic Myelogenous Leukemia or Acute Myelogenous Leukemia or Hairy Cell Leukemia Therapy Area Pipeline Report contains detailed information on the acute lymphoblastic leukemia or leukemia or chronic lymphocytic leukemia or chronic myelogenous leukemia or acute myelogenous leukemia or hairy cell leukemia drug pipeline. This...

4Vote!

Stem Cell Transplant

The news is filled with new discoveries and benefits of stem cell therapy on a daily basis. However, as most stem cell treatments and therapies aren’t yet approved in the U.S., patients are left in a quandry when it comes to potential treatment. However, one of the most commonly performed transplants in the U.S. has been the bone marrow transplant. Since 1968, this treatment has been used to treat...

9Vote!

Blood Cancer | Causes of Blood Cancer | Blood Cancer Treatment

Blood Cancer | Causes of Blood Cancer | Blood Cancer Treatment - sonupt5@gmail.com

Blood Cancer | Causes of Blood Cancer | Blood Cancer Treatment Treating Leukemia, or blood cancer, requires a specialist, like Dr. Delong Liu, M.D. PhD, at Westchester Oncology and Hematology Group. Coming from Albert Einstein College of Medicine, Mt. Sinai Medical Center and Memorial Sloan Kettering Cancer Center where Dr. Liu developed broad expertise in the management of leukemia, lymphoma, aplastic